Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF) Short Interest Update

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF – Get Rating) was the target of a large growth in short interest in the month of December. As of December 30th, there was short interest totalling 552,700 shares, a growth of 22.5% from the December 15th total of 451,100 shares. Based on an average daily volume of 400 shares, the days-to-cover ratio is currently 1,381.8 days.

Ono Pharmaceutical Stock Performance

OPHLF opened at $22.60 on Friday. The company has a fifty day moving average of $23.76 and a two-hundred day moving average of $24.79. The stock has a market capitalization of $11.62 billion, a price-to-earnings ratio of 15.48 and a beta of 0.46. Ono Pharmaceutical has a fifty-two week low of $21.00 and a fifty-two week high of $27.76.

About Ono Pharmaceutical

(Get Rating)

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers OPDIVO intravenous infusions for the treatment of malignant tumors; KYPROLIS for intravenous injection; EMEND capsules/PROEMEND intravenous injections for chemotherapy-induced nausea and vomiting; DEMSER capsules for improvement of the symptoms in patients with pheochromocytoma; and MEKTOVI, VELEXBRU, and ADLUMIZ tablets, as well as BRAFTOVI capsules for malignant tumors.